The rise of gene-related molecular testing has led to the trend of Companion Diagnostics (CDx) and Precision Medicine, and the related technologies have been emphasized by major international testing and reagent companies and pharmaceutical companies and have gradually become an interdependent ecosystem, while major domestic biotech and pharmaceutical companies have also gradually transformed and invested resources in the development of the related fields in the last five years. Major biotech and pharmaceutical companies in China have also been gradually transforming and investing resources in the related fields in the past five years, with Kim Wan Lam, Wise Genetics, and Pulsar showing the most impressive performance.

Table 1 Three major types of genetic tests performed by Taiwan companies

Source: JUPO Product Research, June 2022